Trending

Acorda

Acorda axes Parkinson’s drug after trial deaths

Acorda axes Parkinson’s drug after trial deaths

Biotech not confident white blood cell counts could ensure patient safety.

X

Acorda axes Parkinson’s drug after trial deaths

https://pharmaphorum.com/news/acorda-parkinsons-trial-deaths/

Acorda shares crash after deaths in Parkinson’s trials

Acorda shares crash after deaths in Parkinson’s trials

This could be the end for tozadenant in Parkinson’s disease.

X

Acorda shares crash after deaths in Parkinson’s trials

https://pharmaphorum.com/news/acorda-shares-crash-deaths-parkinsons-trials/

Acorda aims for leadership in Parkinson’s disease with acquisition

Acorda aims for leadership in Parkinson’s disease with acquisition

US specialist pharma company Acorda is to acquire Biotie for $363 million, a move which it hopes will

X

Acorda aims for leadership in Parkinson’s disease with acquisition

https://pharmaphorum.com/news/acorda-aims-for-leadership-in-parkinsons-disease-with-acquisition/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com